ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors to Inquire About Securities Class Action Investigation – CRTX
07 mars 2022 17h12 HE
|
The Rosen Law Firm PA
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, FAT, and Koppers and Encourages Investors to Contact the Firm
04 mars 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Informatica, C3.ai, and Cortexyme and Encourages Investors to Contact the Firm
27 févr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Informatica, Inc. (NYSE:...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cortexyme, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – CRTX
25 févr. 2022 20h45 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 25, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cortexyme, Inc....
ROSEN, A TOP RANKED LAW FIRM, Encourages Cortexyme, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – CRTX
18 févr. 2022 10h37 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cortexyme,...